Rifater

Rifater is a brand name of isoniazid/pyrazinamide/rifampin, approved by the FDA in the following formulation(s):

RIFATER (isoniazid; pyrazinamide; rifampin - tablet; oral)

• 
  Manufacturer: SANOFI AVENTIS US
  
  Approval date: May 31, 1994
  
  Strength(s): 50MG;300MG;120MG ^[RLD]

Has a generic version of Rifater been approved?

No. There is currently no therapeutically equivalent version of Rifater available.

Note: Fraudulent online pharmacies may attempt to sell an illegal generic version of Rifater. These medications may be counterfeit and potentially unsafe. If you purchase medications online, be sure you are buying from a reputable and valid online pharmacy. Ask your health care provider for advice if you are unsure about the online purchase of any medication.

See also: About generic drugs.

Related Patents

There are no current U.S. patents associated with Rifater.

See also...

• Rifater Consumer Information (Wolters Kluwer)
• Rifater Consumer Information (Cerner Multum)
• Rifater Advanced Consumer Information (Micromedex)
• Isoniazid/Pyrazinamide/Rifampin Consumer Information (Wolters Kluwer)
• Isoniazid, pyrazinamide, and rifampin Consumer Information (Cerner Multum)
• Isoniazid/pyrazinamide/rifampin Consumer Information (Cerner Multum)
• Rifampin, isoniazid, and pyrazinamide Advanced Consumer Information (Micromedex)